News

Search:
 Search

Latest News | 5 March 2013

FDA Will Continue to Allow Unapproved Drugs to Receive National Drug Code Numbers

0 Likes

The US Food and Drug Administration (FDA) will continue to grant national drug code (NDC) numbers to pharmaceutical and other drug products not explicitly approved by FDA for a given indication after Read More...


Latest News | 13 December 2012

Repeat Deficiencies Form Basis of Warning Letter to Veterinary Pharmaceutical Manufacturer

0 Likes

A number of recurring deficiencies form the basis of a warning letter sent to a St. Louis veterinary drug manufacturing facility.The company, Performance Products Inc (PPI), was accused of Read More...


Latest News | 6 July 2012

FDA: Stop Manufacturing Unapproved Oxycodone Products

0 Likes

US regulators said they intend to take enforcement action against manufacturers of unapproved oxycodone products, saying the products constitute a “high public health priority” and have a high Read More...


Latest News | 29 June 2012

US Regulators Debar Man for Marketing Unapproved Products

0 Likes

The US Food and Drug Administration (FDA) has issued a debarment order against a man convicted of introducing two pharmaceutical products into interstate commerce in violation of federal law after he Read More...


Latest News | 6 June 2012

Warning Letter Analysis: Medical Device Companies Cited for Marketing Unapproved Products

0 Likes

The US Food and Drug Administration’s (FDA) latest batch of Warning Letters, released 6 June, cites three companies who are alleged to have violated current good manufacturing regulations and, in two Read More...


Latest News | 6 June 2012

J&J Announces Planned Cessation of Vaginal Mesh Sales

0 Likes

Johnson & Johnson subsidiary Ethicon announced on 5 June 2012 it will cease sales of a controversial line of vaginal mesh implant products after being hit with a series of lawsuits alleging the Read More...


Latest News | 30 May 2012

Warning Letter Analysis: Device Companies, Tissue Bank Hit Hard for Deficiencies

0 Likes

The US Food and Drug Administration’s (FDA) newest batch of warning letters was released on 29 May 2012, and some familiar faces have come under further scrutiny. Medical device manufacturer McNeil Read More...


Regulatory Update | 11 May 2012

UK: New Prostate Cancer Drug Extends Life, But NICE Against Reimbursement

0 Likes

Despite the recognized life extending benefits of Sanofi’s new prostate cancer drug, Jevtana (cabazitaxel), the UK's National Institute for Health and Clinical Excellence (NICE) has recommended Read More...


Latest News | 29 February 2012

Medical Device Firm Accused of Selling Unapproved Medical Devices Fined $1 Million

0 Likes

Globus Medical Inc., a Pennsylvania-based medical device manufacturer, has reached an agreement with the US Food and Drug Administration (FDA) to pay a $550,000 fine for reportedly violating the Read More...


RF Today is Regulatory Focus' daily news brief. Each edition contains the top global regulatory news stories about pharmaceuticals, medical devices, biotechnology and more. Learn more

New Regulatory Focus Apps for iPad and iPhone